{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:32:16Z","timestamp":1764732736276,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:00:00Z","timestamp":1527897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370657, 81770166","81470328, 81720108002","81600130"],"award-info":[{"award-number":["81370657, 81770166","81470328, 81720108002","81600130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00277-018-3382-x","type":"journal-article","created":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T02:04:40Z","timestamp":1527905080000},"page":"1841-1849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma"],"prefix":"10.1007","volume":"97","author":[{"given":"Jun-Ying","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4208-7477","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,2]]},"reference":[{"issue":"2","key":"3382_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","volume":"87","author":"M Martelli","year":"2013","unstructured":"Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA (2013) Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol 87(2):146\u2013171. \n                    https:\/\/doi.org\/10.1016\/j.critrevonc.2012.12.009","journal-title":"Crit Rev Oncol Hematol"},{"key":"3382_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.blre.2017.02.005","volume":"31","author":"A Falduto","year":"2017","unstructured":"Falduto A, Cimino F, Speciale A, Musolino C, Gangemi S, Saija A, Allegra A (2017) How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma. Blood Rev 31:235\u2013249. \n                    https:\/\/doi.org\/10.1016\/j.blre.2017.02.005","journal-title":"Blood Rev"},{"issue":"1","key":"3382_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282. \n                    https:\/\/doi.org\/10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"issue":"6","key":"3382_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","volume":"123","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN (2014) An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 123(6):837\u2013842. \n                    https:\/\/doi.org\/10.1182\/blood-2013-09-524108","journal-title":"Blood"},{"key":"3382_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","volume":"70","author":"JW Weisel","year":"2005","unstructured":"Weisel JW (2005) Fibrinogen and fibrin. Adv Protein Chem 70:247\u2013299. \n                    https:\/\/doi.org\/10.1016\/S0065-3233(05)70008-5","journal-title":"Adv Protein Chem"},{"issue":"1","key":"3382_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","volume":"34","author":"D Davalos","year":"2012","unstructured":"Davalos D, Akassoglou K (2012) Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 34(1):43\u201362. \n                    https:\/\/doi.org\/10.1007\/s00281-011-0290-8","journal-title":"Semin Immunopathol"},{"issue":"7","key":"3382_CR7","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-09-3465","volume":"70","author":"KA Steinbrecher","year":"2010","unstructured":"Steinbrecher KA, Horowitz NA, Blevins EA, Barney KA, Shaw MA, Harmel-Laws E, Finkelman FD, Flick MJ, Pinkerton MD, Talmage KE, Kombrinck KW, Witte DP, Palumbo JS (2010) Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen. Cancer Res 70(7):2634\u20132643. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3465","journal-title":"Cancer Res"},{"issue":"7203","key":"3382_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444. \n                    https:\/\/doi.org\/10.1038\/nature07205","journal-title":"Nature"},{"issue":"18","key":"3382_CR9","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1182\/blood-2010-11-316885","volume":"117","author":"KR Machlus","year":"2011","unstructured":"Machlus KR, Cardenas JC, Church FC, Wolberg AS (2011) Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 117(18):4953\u20134963. \n                    https:\/\/doi.org\/10.1182\/blood-2010-11-316885","journal-title":"Blood"},{"issue":"5","key":"3382_CR10","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1182\/blood-2006-08-040956","volume":"109","author":"GA Tennent","year":"2007","unstructured":"Tennent GA, Brennan SO, Stangou AJ, O'Grady J, Hawkins PN, Pepys MB (2007) Human plasma fibrinogen is synthesized in the liver. Blood 109(5):1971\u20131974. \n                    https:\/\/doi.org\/10.1182\/blood-2006-08-040956","journal-title":"Blood"},{"issue":"7","key":"3382_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12032-014-0022-8","volume":"31","author":"HG Jiang","year":"2014","unstructured":"Jiang HG, Li J, Shi SB, Chen P, Ge LP, Jiang Q, Tang XP (2014) Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer. Med Oncol 31(7):22. \n                    https:\/\/doi.org\/10.1007\/s12032-014-0022-8","journal-title":"Med Oncol"},{"issue":"10","key":"3382_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ctrv.2015.10.002","volume":"41","author":"C Perisanidis","year":"2015","unstructured":"Perisanidis C, Psyrri A, Cohen EE, Engelmann J, Heinze G, Perisanidis B, Stift A, Filipits M, Kornek G, Nkenke E (2015) Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev 41(10):960\u2013970. \n                    https:\/\/doi.org\/10.1016\/j.ctrv.2015.10.002","journal-title":"Cancer Treat Rev"},{"key":"3382_CR13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1007\/s00268-017-3991-x","volume":"41","author":"K Wakatsuki","year":"2017","unstructured":"Wakatsuki K, Matsumoto S, Migita K, Ito M, Kunishige T, Nakade H, Nakatani M, Kitano M, Sho M (2017) Preoperative plasma fibrinogen is associated with lymph node metastasis and predicts prognosis in resectable esophageal cancer. World J Surg 41:2068\u20132077. \n                    https:\/\/doi.org\/10.1007\/s00268-017-3991-x","journal-title":"World J Surg"},{"issue":"1","key":"3382_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1538-7836.2007.02808.x","volume":"6","author":"A Sahni","year":"2008","unstructured":"Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW (2008) Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost 6(1):176\u2013183. \n                    https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02808.x","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3382_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/cas.13127","volume":"108","author":"T Kijima","year":"2017","unstructured":"Kijima T, Arigami T, Uchikado Y, Uenosono Y, Kita Y, Owaki T, Mori S, Kurahara H, Kijima Y, Okumura H, Maemura K, Ishigami S, Natsugoe S (2017) Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma. Cancer Sci 108(2):193\u2013199. \n                    https:\/\/doi.org\/10.1111\/cas.13127","journal-title":"Cancer Sci"},{"issue":"4","key":"3382_CR16","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1182\/blood-2002-05-1416","volume":"101","author":"M Cushman","year":"2003","unstructured":"Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR (2003) Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 101(4):1243\u20131248. \n                    https:\/\/doi.org\/10.1182\/blood-2002-05-1416","journal-title":"Blood"},{"issue":"1","key":"3382_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1160\/TH04-04-0260","volume":"93","author":"T Sase","year":"2005","unstructured":"Sase T, Wada H, Yamaguchi M, Ogawa S, Kamikura Y, Nishikawa M, Kaneko T, Abe Y, Nishioka J, Nobori T, Shiku H (2005) Haemostatic abnormalities and thrombotic disorders in malignant lymphoma. Thromb Haemost 93(1):153\u2013159. \n                    https:\/\/doi.org\/10.1160\/TH04-04-0260","journal-title":"Thromb Haemost"},{"issue":"4","key":"3382_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/jclinpath-2015-203356","volume":"69","author":"KT Troppan","year":"2016","unstructured":"Troppan KT, Melchardt T, Wenzl K, Schlick K, Deutsch A, Bullock MD, Reitz D, Beham-Schmid C, Weiss L, Neureiter D, Trankenschuh W, Greil R, Neumeister P, Egle A, Pichler M (2016) The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma. J Clin Pathol 69(4):326\u2013330. \n                    https:\/\/doi.org\/10.1136\/jclinpath-2015-203356","journal-title":"J Clin Pathol"},{"issue":"Suppl 2","key":"3382_CR19","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0049-3848(14)50009-6","volume":"133","author":"PW Kamphuisen","year":"2014","unstructured":"Kamphuisen PW, Beyer-Westendorf J (2014) Bleeding complications during anticoagulant treatment in patients with cancer. Thromb Res 133(Suppl 2):S49\u2013S55. \n                    https:\/\/doi.org\/10.1016\/S0049-3848(14)50009-6","journal-title":"Thromb Res"},{"issue":"10","key":"3382_CR20","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100(10):3484\u20133488. \n                    https:\/\/doi.org\/10.1182\/blood-2002-01-0108","journal-title":"Blood"},{"issue":"1","key":"3382_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1634\/theoncologist.2013-0239","volume":"19","author":"NJ Short","year":"2014","unstructured":"Short NJ, Connors JM (2014) New oral anticoagulants and the cancer patient. Oncologist 19(1):82\u201393. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2013-0239","journal-title":"Oncologist"},{"issue":"12","key":"3382_CR22","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","volume":"124","author":"N Es van","year":"2014","unstructured":"van Es N, Coppens M, Schulman S, Middeldorp S, Buller HR (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 124(12):1968\u20131975. \n                    https:\/\/doi.org\/10.1182\/blood-2014-04-571232","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3382-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:32:55Z","timestamp":1559439175000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3382-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,2]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3382"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3382-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2018,6,2]]},"assertion":[{"value":"18 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}